Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 29:9:986176.
doi: 10.3389/fmed.2022.986176. eCollection 2022.

Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study

Zhao Li  1   2 , Qun Wang  1 , Shi-Feng Zhang  1   2 , Yi-Fei Huang  1 , Li-Qiang Wang  1
Affiliations

Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study

Zhao Li et al. Front Med (Lausanne). .

Abstract

Purpose: To summarize and discuss the treatment and timing of glaucoma in patients with MICOF keratoprosthesis implantation to guide follow-up clinical treatment.

Methods: The data of 39 eyes (39 patients) with the Moscow Eye Microsurgery Complex in Russia (MICOF) keratoprosthesis implantation in our hospital from 1 January 2002 to 31 December 2017 were collected, including patients with preexisting glaucoma and those who developed glaucoma de novo after MICOF. The sex, age, preoperative diagnosis, glaucoma surgery, keratoplasty, times of keratoplasty, best corrected visual acuity (BCVA) and final follow-up corrected visual acuity, visual field (VF) defect, and cup-to-disk ratio (CDR) were statistically analyzed.

Results: Among 16 eyes with preexisting glaucoma, eight eyes underwent glaucoma surgery before MICOF, 4 eyes underwent glaucoma surgery combined with MICOF, and four eyes were managed medically. Among 23 eyes with de novo glaucoma, seven eyes were treated with surgery and 16 eyes were treated with medication only. A total of 9 (56.3%) eyes had corneal transplants with preexisting glaucoma, which was a higher percentage than that in the patients with de novo glaucoma (n = 5, 21.7%, P = 0.043). In both the preexisting glaucoma group and the de novo glaucoma group, the most common causes were alkali burns (56.3% of preexisting glaucoma and 43.5% of de novo glaucoma). There was no significant difference between the operation and initial visual acuity, postoperative visual acuity, BCVA, CDR, or VF defect. In the de novo glaucoma group, the final follow-up visual acuity of the glaucoma surgery group (1.56 ± 1.07) was worse than that of the mediation group (0.44 ± 0.53) (P < 0.017). Among the complications, the incidence of cornea melting in the patients treated with medications only (n=10) was significantly higher than that in the patients treated with glaucoma surgery (n = 0, P = 0.007), but there was no significant difference in the other complications.

Conclusion: Among patients with MICOF, those patients who have undergone keratoplasty are more likely to develop glaucoma before surgery and glaucoma needs to be prevented. Surgical treatment can be selected according to the ocular surface condition in the patients with de novo glaucoma to reduce the occurrence of complications.

Keywords: KPro; MICOF; glaucoma; retrospective clinical study; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The Kaplan–Meier survival curve for visual field loss to compare the timing of glaucoma surgery and medication.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Shimazaki J, Shimmura S, Tsubota K. Donor source affects the outcome of ocular surface reconstruction in chemical or thermal burns of the cornea. Ophthalmology. (2004) 111:38–44. 10.1016/j.ophtha.2003.02.003 - DOI - PubMed
    1. Meduri A, Valastro A, Inferrera L, Oliverio GW, Ninotta I, Camellin U, et al. . Sutureless amniotic membrane transplantation in inflammatory corneal perforations. Appl Sci. (2022) 12:3924–33. 10.3390/app12083924 - DOI
    1. Ilhan-Sarac O, Akpek EK. Current concepts and techniques in keratoprosthesis. Curr Opin Ophthalmol. (2005) 16:246–50. 10.1097/01.icu.0000172829.33770.d3 - DOI - PubMed
    1. de Oliveira LA, Magalhães FP, Hirai FE, de Sousa LB. Experience with Boston keratoprosthesis type 1 in the developing world. Can J Ophthalmol. (2014) 49:351–7. 10.1016/j.jcjo.2014.05.003 - DOI - PubMed
    1. Hille K, Grabner G, Liu C, Colliardo P, Falcinelli G, Taloni M, et al. . Standards for modified osteoodontokeratoprosthesis (OOKP) surgery according to Strampelli and Falcinelli: the Rome-Vienna Protocol. Cornea. (2005) 24:895–908. 10.1097/01.ico.0000157401.81408.62 - DOI - PubMed

LinkOut - more resources